D M Nunes1, A C M Maia2, R C Boni3, A J da Rocha2. 1. From the Section of Neuroradiology (D.M.N., A.C.M.M.Jr., A.J.d.R.) douglasmendesnunes@gmail.com. 2. From the Section of Neuroradiology (D.M.N., A.C.M.M.Jr., A.J.d.R.). 3. Section of Organ Procurement Organization (R.C.B.), Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brazil.
Abstract
BACKGROUND AND PURPOSE: Intracranial pressure modifications caused by a skull defect, such as craniectomy or craniotomy, may change the hemodynamics and decrease the accuracy of CTA to confirm brain death. This study aimed to evaluate the impact of a skull defect and the interpretation criteria of images on this diagnostic test. MATERIALS AND METHODS: A series of consecutive patients with a clinical diagnosis of brain death underwent CTA (case group), while the control group comprised patients with acute ischemic stroke in the same period. CTA criteria adopted to confirm brain death were the absence of opacification of the M4 branches and internal cerebral veins. The evaluation also included the presence of "stasis filling." Cases were stratified as intact skull, craniotomy, and craniectomy. Three neuroradiologists evaluated all examinations independently. RESULTS: In the case group, according to the Frampas criteria, the sensitivity of CTA to confirm brain death was 95.5% in patients with intact skull, 87.5% with craniotomy, and 60% with craniectomy. False-negative diagnoses of brain death were 15.6%, related to stasis filling in 71.4% (P < .001). However, according to the "modified Frampas criteria," the sensitivity of CTA to confirm brain death was 100% in patients with intact skull, 93.8% with craniotomy, and 80% with craniectomy. False-negative diagnoses of brain death were found in 6.2% of patients, and there was no stasis filling. CTA showed 100% specificity in the control group. There were no disagreements among observers. CONCLUSIONS: CTA had a high diagnostic accuracy and reproducibility to confirm brain death in patients with an intact skull. The modified Frampas criteria increased the sensitivity of CTA, particularly in patients with a skull defect. A concurrent skull defect, especially craniectomy, can decrease the sensitivity of CTA to confirm brain death.
BACKGROUND AND PURPOSE: Intracranial pressure modifications caused by a skull defect, such as craniectomy or craniotomy, may change the hemodynamics and decrease the accuracy of CTA to confirm brain death. This study aimed to evaluate the impact of a skull defect and the interpretation criteria of images on this diagnostic test. MATERIALS AND METHODS: A series of consecutive patients with a clinical diagnosis of brain death underwent CTA (case group), while the control group comprised patients with acute ischemic stroke in the same period. CTA criteria adopted to confirm brain death were the absence of opacification of the M4 branches and internal cerebral veins. The evaluation also included the presence of "stasis filling." Cases were stratified as intact skull, craniotomy, and craniectomy. Three neuroradiologists evaluated all examinations independently. RESULTS: In the case group, according to the Frampas criteria, the sensitivity of CTA to confirm brain death was 95.5% in patients with intact skull, 87.5% with craniotomy, and 60% with craniectomy. False-negative diagnoses of brain death were 15.6%, related to stasis filling in 71.4% (P < .001). However, according to the "modified Frampas criteria," the sensitivity of CTA to confirm brain death was 100% in patients with intact skull, 93.8% with craniotomy, and 80% with craniectomy. False-negative diagnoses of brain death were found in 6.2% of patients, and there was no stasis filling. CTA showed 100% specificity in the control group. There were no disagreements among observers. CONCLUSIONS: CTA had a high diagnostic accuracy and reproducibility to confirm brain death in patients with an intact skull. The modified Frampas criteria increased the sensitivity of CTA, particularly in patients with a skull defect. A concurrent skull defect, especially craniectomy, can decrease the sensitivity of CTA to confirm brain death.
Authors: Dolores Escudero; Jesús Otero; Lara Marqués; Diego Parra; José Antonio Gonzalo; Guillermo M Albaiceta; Luis Cofiño; Armando Blanco; Pedro Vega; Eduardo Murias; Angela Meilan; Ricardo López Roger; Francisco Taboada Journal: Neurocrit Care Date: 2009-06-30 Impact factor: 3.210
Authors: B Dupas; M Gayet-Delacroix; D Villers; D Antonioli; M F Veccherini; J P Soulillou Journal: AJNR Am J Neuroradiol Date: 1998-04 Impact factor: 3.825
Authors: Mark P Garrett; Richard W Williamson; Michael A Bohl; C Roger Bird; Nicholas Theodore Journal: J Neurosurg Date: 2017-03-17 Impact factor: 5.115
Authors: E Frampas; M Videcoq; E de Kerviler; F Ricolfi; V Kuoch; F Mourey; A Tenaillon; B Dupas Journal: AJNR Am J Neuroradiol Date: 2009-04-30 Impact factor: 3.825